ATP site-directed inhibitors of protein kinase CK2: an update

Keyphrases

• Protein Kinase 100%
• Protein Kinase Inhibitors 100%
• Protein Kinase CK2 100%
• CK2 Inhibitors 100%
• Site-directed 100%
• ATP Site 100%
• Cancer Cells 66%
• Promiscuity 66%
• 3D Structure 33%
• Chlorine 33%
• Apoptosis 33%
• Clinical Trials 33%
• TETRA 33%
• Constitutively Active 33%
• Catalytic Subunit 33%
• Side Chain 33%
• Biological Function 33%
• Selective Inhibitor 33%
• Cell Permeable 33%
• High Selectivity 33%
• Active Protein 33%
• Iodine 33%
• Benzimidazole 33%
• Rational Development 33%
• Hydrophobic Interaction 33%
• Multiple Myeloma 33%
• Bromine 33%
• Halogenated 33%
• Non-oncogene Addiction 33%
• Homeodomain-interacting Protein Kinase 2 (HIPK2) 33%
• CX-4945 33%
• Advanced Solid Tumors 33%
• Castelman Disease 33%
• Quinalizarin 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Adenosine Triphosphate 100%
• Protein Kinases 100%
• Casein Kinase II 100%
• Malignant Neoplasm 66%
• Solid Malignant Neoplasm 33%
• Disease 33%
• Clinical Trial 33%
• Alanine 33%
• Benzimidazole Derivative 33%
• Multiple Myeloma 33%
• Carbon Tetrachloride 33%
• Oncogene Addiction 33%
• Quinalizarin 33%